Literature DB >> 19539891

How valid are current cervical cancer prognostic factors that are used to recommend adjunctive radiation therapy after radical surgery?

William T Creasman1, Matthew Kohler, Jeffrey E Korte.   

Abstract

Prognostic factors in early cervical cancer have been debated for many years and have been used as an indication for postradical hysterectomy radiation therapy. A recent Gynecologic Oncology Group protocol suggested that large lesions, deep invasion, or capillary-like space had better recurrence-free survival, but not overall survival, if postoperative radiation was given. When the published data were evaluated, the authors' conclusions were questioned. The choice of prognostic factors does not seem appropriate based on the data that were presented.

Entities:  

Mesh:

Year:  2009        PMID: 19539891     DOI: 10.1016/j.ajog.2009.04.020

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  1 in total

1.  Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis.

Authors:  Kimberly Levinson; Anna L Beavis; Christopher Purdy; Anne F Rositch; Akila Viswanathan; Aaron H Wolfson; Michael G Kelly; Krishnansu S Tewari; Leah McNally; Saketh R Guntupalli; Omar Ragab; Yi-Chun Lee; David S Miller; Warner K Huh; Kelly J Wilkinson; Nicola M Spirtos; Linda Van Le; Yovanni Casablanca; Laura L Holman; Steven E Waggoner; Amanda N Fader
Journal:  Gynecol Oncol       Date:  2021-07-01       Impact factor: 5.304

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.